Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J Investors Need to Decide Soon If They Want Kenvue Stock
02:27pm, Monday, 14'th Aug 2023
The $40 billion exchange offer for shares of Kenvue expires Friday but brokerage firms want retail investors to make their instructions before then
Meet the Only 2 Publicly Traded Companies With a Higher Credit Rating Than the U.S. Government
05:21am, Monday, 14'th Aug 2023
Two weeks ago, Fitch downgraded the U.S. credit rating from AAA to AA+. This matched the downgrade issued by Standard & Poor's (S&P) in 2011.
5 Best Stocks to Buy in a Bear Market
01:49pm, Saturday, 12'th Aug 2023
In the ever-fluctuating stock market landscape, navigating bear markets can be a nerve-wracking experience for even the most seasoned investors. When stock prices plunge and economic clouds gather, it
3 Unstoppable Dividend Stocks to Buy Right Now
06:15am, Saturday, 12'th Aug 2023
AbbVie is more unstoppable than you might think. Johnson & Johnson faces some challenges but remains a solid pick for long-term investors.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Johnson & Johnson (JNJ) Could Be a Great Choice
01:02pm, Friday, 11'th Aug 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
These 10 medications are likely targets for Medicare price negotiations this fall
01:22pm, Thursday, 10'th Aug 2023
It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
J&J spinoff Kenvue set to join S&P 500 index
08:52am, Thursday, 10'th Aug 2023
Kenvue is set to make its debut in the S&P 500 index, a move confirmed by S&P Dow Jones Indices following the impending completion of Johnson and Johnson's exchange offer for Kenvue stock. The inclusi
US FDA approves J&J's blood cancer therapy
06:49am, Thursday, 10'th Aug 2023
Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
The 7 Safest Stocks to Buy in August
05:15am, Thursday, 10'th Aug 2023
As the Nasdaq starts to plateau and more economists signal volatility ahead, it might once again be time to look for a port in the storm. Last year, investors that bought into the safest stocks had s
Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock.
01:00am, Thursday, 10'th Aug 2023
Holders of odd lots under 100 shares should come out ahead after J&J splits off its Kenvue unit.
Kenvue Will be Added to S&P 500 After J&J Exchange Offer
06:16pm, Wednesday, 09'th Aug 2023
The Johnson & Johnson spinoff is the consumer health company that makes Listerine and Tylenol.
Kenvue, the J&J spinoff, will join the S&P 500 index
05:49pm, Wednesday, 09'th Aug 2023
Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500, index provider S&P Dow Jones Indices said late Wednesday.
5 Defensive Stocks for Stable Returns Amid Recent Volatility
09:12am, Wednesday, 09'th Aug 2023
We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.
Johnson & Johnson's Talc Problems Aren't Going Away
08:45am, Wednesday, 09'th Aug 2023
Earlier this year, Johnson & Johnson made an $8.9 billion offer to plaintiffs to settle its talc liabilities. A federal judge recently put those plans into doubt by rejecting the company's efforts to
